Fig. 1.

Positive detection rate for IgA and IgM at an early stage of SARS-CoV-2 infection_
| IgA | IgM | Time point | Target antigen | Principles | References | ||
|---|---|---|---|---|---|---|---|
| IgA | IgM | IgA | IgM | ||||
| 100% | 0% | 5–7 days | S1 | N + S | ELISA | CLIA | Infantino et al. 2021 |
| 92.7% | 85.4% | 1–7 days | N | N | ELISA | ELISA | Guo et al. 2020 |
| 31.3% | 14.6% | 1–7 days | RBD | RBD | PRI | PRI | Sterlin et al. 2021 |
| 23.0% | 2.1% | 1–7 days | N | N | PRI | PRI | Sterlin et al. 2021 |
| 60.0% | 53.3% | 1–7 days | N | N | ELISA | ELISA | Zervou et al. 2021 |
| 28.0% | 10% | 1–7 days | N/S | N/S | CMIA | CMIA | Pisanic et al. 2021 |
| 50.0%* | 0%* | 1–7 days | N/S | N/S | CMIA | CMIA | Pisanic et al. 2021 |